Literature DB >> 2322091

Cholecystokinin-4 and panic.

J L Abelson, R M Nesse.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2322091     DOI: 10.1001/archpsyc.1990.01810160095016

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


× No keyword cloud information.
  7 in total

Review 1.  Neuropeptide regulation of fear and anxiety: Implications of cholecystokinin, endogenous opioids, and neuropeptide Y.

Authors:  Mallory E Bowers; Dennis C Choi; Kerry J Ressler
Journal:  Physiol Behav       Date:  2012-03-10

2.  Pentagastrin has panic-inducing properties in obsessive compulsive disorder.

Authors:  A S de Leeuw; J A Den Boer; B R Slaap; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

3.  The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.

Authors:  L Singh; M J Field; J Hughes; R Menzies; R J Oles; C A Vass; G N Woodruff
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

4.  Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.

Authors:  H J van Megen; H G Westenberg; J A den Boer; J R Haigh; M Traub
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

5.  Cholecystokinin and anxiety in normal volunteers: an investigation of the anxiogenic properties of pentagastrin and reversal by the cholecystokinin receptor subtype B antagonist L-365,260.

Authors:  C Lines; J Challenor; M Traub
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

6.  Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.

Authors:  J Bradwejn; D Koszycki; A Couëtoux du Tertre; M Paradis; M Bourin
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

7.  Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats.

Authors:  P T Männistö; A Lang; J Harro; E Peuranen; J Bradwejn; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.